Cargando…
Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates
SIMPLE SUMMARY: With the increasing rates of early-stage hepatocellular carcinoma (HCC) diagnosis, patients are being diagnosed with less tumor burden and low biomarker levels. Assessing HCC prognosis in these patients is challenging as most prognosis strategies are based on elevated tumor burden an...
Autores principales: | Núñez, Kelley G., Sandow, Tyler, Patel, Jai, Hibino, Mina, Fort, Daniel, Cohen, Ari J., Thevenot, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996921/ https://www.ncbi.nlm.nih.gov/pubmed/35406456 http://dx.doi.org/10.3390/cancers14071684 |
Ejemplares similares
-
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
por: Núñez, Kelley G., et al.
Publicado: (2021) -
PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
por: Núñez, Kelley G., et al.
Publicado: (2021) -
Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy
por: Núñez, Kelley G., et al.
Publicado: (2022) -
Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation
por: Núñez, Kelley, et al.
Publicado: (2020) -
Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
por: Koksal, Ali Riza, et al.
Publicado: (2022)